Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review.
BACKGROUND
Outbreaks of emerging infectious diseases, especially those of a global nature, require rapid epidemiological analysis and information dissemination. The final products of those activities usually comprise internal memoranda and briefs within public health authorities and original research published in peer-reviewed journals. Using the 2003 severe acute respiratory syndrome (SARS) epidemic as an example, we conducted a comprehensive time-stratified review of the published literature to describe the different types of epidemiological outputs.


RESULTS
We identified and analyzed all published articles on the epidemiology of the SARS outbreak in Hong Kong or Toronto. The analysis was stratified by study design, research domain, data collection, and analytical technique. We compared the SARS-case and matched-control non-SARS articles published according to the timeline of submission, acceptance, and publication. The impact factors of the publishing journals were examined according to the time of publication of SARS articles, and the numbers of citations received by SARS-case and matched-control articles submitted during and after the epidemic were compared. Descriptive, analytical, theoretical, and experimental epidemiology concerned, respectively, 54%, 30%, 11%, and 6% of the studies. Only 22% of the studies were submitted, 8% accepted, and 7% published during the epidemic. The submission-to-acceptance and acceptance-to-publication intervals of the SARS articles submitted during the epidemic period were significantly shorter than the corresponding intervals of matched-control non-SARS articles published in the same journal issues (p<0.001 and p<0.01, respectively). The differences of median submission-to-acceptance intervals and median acceptance-to-publication intervals between SARS articles and their corresponding control articles were 106.5 d (95% confidence interval [CI] 55.0-140.1) and 63.5 d (95% CI 18.0-94.1), respectively. The median numbers of citations of the SARS articles submitted during the epidemic and over the 2 y thereafter were 17 (interquartile range [IQR] 8.0-52.0) and 8 (IQR 3.2-21.8), respectively, significantly higher than the median numbers of control article citations (15, IQR 8.5-16.5, p<0.05, and 7, IQR 3.0-12.0, p<0.01, respectively).


CONCLUSIONS
A majority of the epidemiological articles on SARS were submitted after the epidemic had ended, although the corresponding studies had relevance to public health authorities during the epidemic. To minimize the lag between research and the exigency of public health practice in the future, researchers should consider adopting common, predefined protocols and ready-to-use instruments to improve timeliness, and thus, relevance, in addition to standardizing comparability across studies. To facilitate information dissemination, journal managers should reengineer their fast-track channels, which should be adapted to the purpose of an emerging outbreak, taking into account the requirement of high standards of quality for scientific journals and competition with other online resources.
Xing
Weijia
W
INSERM, U707, Paris, France. weijia.xing@inserm.fr
Hejblum
Gilles
G
Leung
Gabriel M
GM
Valleron
Alain-Jacques
AJ
D015706:Bibliometrics; D035843:Biomedical Research / Q000706:statistics & numerical data; D002170:Canada / Q000453:epidemiology; D004196:Disease Outbreaks / Q000706:statistics & numerical data*; D035081:Editorial Policies; D004813:Epidemiology / Q000706:statistics & numerical data*; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D033181:Information Dissemination / Q000379:methods; D017712:Peer Review, Research; D010506:Periodicals as Topic / Q000706:statistics & numerical data*; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology*; D013997:Time Factors
N Engl J Med. 2003 May 15;348(20):1977-85
12671062
Nature. 2008 Feb 21;451(7181):990-3
18288193
Emerg Infect Dis. 1998 Jan-Mar;4(1):21-7
9452395
Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1091-105
15306395
Proc Biol Sci. 2004 Nov 7;271(1554):2223-32
15539347
Lancet. 2009 Jun 20;373(9681):2085-6
19541022
N Engl J Med. 2003 May 15;348(20):1995-2005
12671061
Can J Public Health. 2006 Jan-Feb;97(1):42-4
16512327
J Virol. 2006 Sep;80(18):8920-8
16940504
Lancet Infect Dis. 2001 Dec;1(5):345-53
11871807
Wkly Epidemiol Rec. 2003 Mar 14;78(11):73-4
12674023
Lancet. 2003 May 24;361(9371):1761-6
12781533
Clin Infect Dis. 2005 Apr 15;40(8):1079-86
15791504
J Altern Complement Med. 2005 Feb;11(1):49-55
15750363
Ann Intern Med. 2004 Nov 2;141(9):662-73
15520422
Nature. 2004 Jul 8;430(6996):242-9
15241422
PLoS Med. 2007 Oct 16;4(10):e296
17941714
Emerg Infect Dis. 2006 Jan;12(1):110-3
16494726
Am J Epidemiol. 1990 Jul;132(1):9-16
2356818
BMJ. 2004 Mar 20;328(7441):702-8
15031246
JAMA. 2004 May 26;291(20):2483-7
15161900